Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

Market Cap	4.30B
Revenue (ttm)	359.06M
Net Income (ttm)	38.80M
Shares Out	219.49M
EPS (ttm)	0.18
PE Ratio	108.22
Forward PE	n/a
Dividend	1.23 (6.29%)
Ex-Dividend Date	Jun 12, 2025

Volume	1,604,397
Average Volume	4,099,573
Open	19.09
Previous Close	19.54
Day's Range	19.09 - 19.67
52-Week Range	15.31 - 23.28
Beta	0.29
RSI	40.10
Earnings Date	Aug 28, 2025

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 812
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002932

Financial Performance

In 2024, SHE:002932's revenue was 350.06 million, a decrease of -53.30% compared to the previous year's 749.54 million. Earnings were 74.52 million, a decrease of -0.54%.